Why Are Drugs Getting Such Weird Brand Names?

Xconomy National — 

Oddball product names are one of the occupational hazards of biotech writing. Drugs in particular can be hard to spell, and often hard to pronounce. While I can practically type telaprevir, telaprevir, telaprevir in my sleep at this point, I can almost feel the reader reaction when that scientific name flows from my keyboard.


Alas, there’s no Steve Jobs-style marketing whiz in this business, handing down tablets from the heavens, and bestowing upon them a magical name like “iPad.” But lately, the business of giving brand names to prescription drugs seems to have gone from boring to weird.

Check a few of the newly-coined drug names—Incivek, Adcetris, Yervoy, Viibryd, Zytiga, Xgeva. Somewhere, the folks who sell Coca-Cola must be giggling at their friends who went into pharmaceuticals. How are you supposed to create an identity for a product, when people can’t even spell or pronounce it, much less have any sense of what it means?

There’s a reason so many drug names look so weird. A good drug name is supposed to check lots of boxes. It should be easy for doctors to spell accurately when they scribble it down on a prescription pad. It should be memorable. It should be used in every country around the world without triggering some cultural confusion or sensitivity. It ought to be consistent with the science or clinical application that distinguished the product through years of development, yet the brand name shouldn’t be so geeky that it’s obtuse for patients. Ideally, you’d want it to trigger some relevant connection to your product.

It’s all easier said than done, says Vince Budd, the senior vice president at Addison Whitney, a brand consulting firm in Charlotte, NC. Besides the creative challenge of doing all that, there are legal and regulatory barriers for pharma companies. Lawyers for the drug companies watch carefully to make sure no one is infringing on any of their thousands of brand trademarks, to make sure nobody can ride the coattails of a consumer hit like Pfizer’s sildenafil (Viagra). Once a name can be shown to be unique from a trademark perspective, it’s still got a long way to go. Companies can easily spend more than a year, sometimes two years, getting through the creative process, the trademark process, and then FDA approval process.

The FDA is getting particularly tough, rejecting about four out of every 10 name proposals, because it wants to avoid medication mix-ups that can lead to dangerous—sometimes deadly—adverse reactions, Budd says. The poster child for brand confusion is Celebrex (a pain medication) getting mixed up with Celexa (an anti-depressant).

“If you want to name a potato chip, all you have to know is whether you can own the trademark,” Budd says. The effort to become uber-differentiated from everything else in pharmaceuticals, Budd says, leads to some of those new names you see. “You’re getting names that are crazier and crazier,” he says.

There are really two different of drugs to think about for naming purposes. There are drugs that are trying to reach mainstream consumers, and drugs that really only need to connect with physicians. Budd, whose firm helped name a new drug for depression, Viibryd, was hoping to convey … Next Page »

Single PageCurrently on Page: 1 2

By posting a comment, you agree to our terms and conditions.

23 responses to “Why Are Drugs Getting Such Weird Brand Names?”

  1. David Goldfarb says:

    Amen, brother. As a pharma marketer, it seems to me the objective is to occupy a space in the mind of the prescriber on the way to “top of mind in the category.” Being uniquely odd just isn’t aiming high enough. One suspects that professional namers are simply keyboarding parameters into a program, letting it run and editing out the candidates with no vowels at all. Does this work? Sure. But naming could be done so much better.

  2. Drum roll please….the votes are in on the best and worst drug names. Here are the top 10 worst names, as selected by you the readers by 6 pm Eastern/3 pm Pacific time.


    I’ll add another comment for the names you voted in as the best.

  3. Here are the votes for the best drug names:


    The polls are now closed. SurveyMonkey wants me to pay for more results, and since this was just for fun, I’m not going to. I’m not sure what to conclude here, other than we have a lot of Dendreon fans stuffing the ballot box, like many probably will for Ichiro at this year’s All-Star game. Thanks for sharing your thoughts!

  4. Ellen M Martin says:

    Viibryd sounds like a new humanoid species in a science fiction universe…

  5. i also voted for Provenge as the one i like most because its an action name..the revenge of of the prostate to ward off cancer cells.easier for the doctors to recall and “feel good” for patients.I dont like Galise because in the Philippines Galis is a stubborn wound.It should avoid this connotation if it wants to gain a good international brand image.Overall thank you for the mental exercise.

    • waaa says:

      In fact, it sounds like proactive revenge. Vengeance carried out even before the need for re-venge.

  6. LJ says:

    It is Gralise, not Galise. And it is now Depomed’s, not Abbott’s.

  7. LJ—good catch, thanks. After writing this, I also realize I forgot a few drugs that would have been fun to include in the mix. I’m thinking of Arena Pharmaceuticals’ lorcaserin (Lorqess) for obesity, Orexigen Therapeutics’ combination of naltrexone and bupropion (Contrave) for obesity, Amylin Pharmaceuticals exenatide once-weekly (Bydureon) for diabetes, and Optimer Pharmaceuticals’ fidaxomicin (Dificid) for C. difficile infections.

  8. Completely agree. Naming products in the pharma space is so much more cpmplex as there are even more criteria to consider beyond brand image and the basic marketing criteria. All the good ones are taken. Not surprised about the results of the poll. The best names are still easy to pronounce and spell. Even in pharma.

    Nice post. Well done.

  9. Leonard Drake says:

    I am baffled by half of the names of the newer medications being advertised: Yaz, Beyaz, Lyrica, et al. When I think of “Lyrica,” I think of someone or something singing. “Lyrica” has no relation to fibromyalgia, but then again, the name Tylenol doesn’t “scream” headache, either.

    And Yaz? Ever since problems were reported with Yaz we can “BE Yaz?” What the….?

  10. camerique says:

    tocilizumab, denosumab, ipilimumab… how about yabbadabbadomobabababy?

  11. waaa says:

    Lets be sensitive, there’s been a lot of violence in the Edarbi region lately…

  12. DontCopALatuda says:

    New drug names are making me furious!! The fury began with Latuda. (????) WhoTF came up with that gem? Need to adjust adjust your la-atti-tuda?!? I hate it, I hate it so much. I hate it beyond words. It makes my head ache. Next, I heard (and also hated) Januvia. Is that Latuda’s sister? WTF?!? Just heard an ad for Harvoni. Reeeaally?? Huh, that must be Victoza’s brother. WhoTF is naming this f’d up family?!? You can’t be serious. These are the stupidest, most annoying drug names in the history of drug names. I don’t care what ailment I develop, I’d rather suffer with whatever-it-is than take one of these absurdly, asininely, ridiculously named drugs. Really, I won’t take them based on their names alone. I won’t, I will not… ever.
    Wait…. Will any of these meds prevent a stroke?!?!? Merely hearing them is about to give me one.

  13. Stephen Hale says:

    So, in other words, it’s a [email protected] story. I have never been able to pronounce my Omeprazole with success and know I know it’s some stupid [email protected] making $hit up. It makes me want to throw up. The Pharm colleges need to create an atmosphere where they become adjudicate. These [email protected] make me want to puke.

  14. Stephen Hale says:

    Pharm guys, we get your acumen and your education. You don’t need to confuse old people with legitimist prognition and pretend BULLSHIT. God, where the days when honest men and women tried to help people, when the learned tried to heal, when self advancing men and women loved to be helpful. GODD DAMN YOU ALL. You are a blight on this civilization. Money hungry FUCKS.

  15. Eric Schrader says:

    I hate these effing names. The drug companies think they’re so cute. Some A-hole stays up all night thinking of this crap.

  16. 2AshlinPoplin says:

    Useful comments – I learned a lot from the analysis – Does anyone know where my company could possibly locate a blank a form document to fill in ?

  17. Kang Dindu says:

    Forgive the rimjob I’m about to give you, but this is a very well written article and I wish all people would write like this.